Diabetes Clinical Trials in Portland

Showing 161-180 of 197 trials

The Multi-Sensor Distance Accuracy Study

NCT02241993

The purpose of the study is to test the accuracy benefit of having two glucose sensors (over one sensor alone) when they are positioned: 2mm, 10mm, 20mm, or 30mm apart. It is not yet known how close two sensors can be and still work correctly.

Type 1 Diabetes Mellitus

Oregon Health and Science University20 participantsStarted Jul 2010

Portland, Oregon, United States

COMPLETEDPHASE4< 1 mile

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

NCT01107886

The purpose of this study is to determine whether saxagliptin can reduce the risk of cardiovascular events when used alone or added to other diabetes medications

Type 2 Diabetes Mellitus

AstraZeneca18,206 participantsStarted May 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tempe, Arizona, United States +533 more locations

The Multi-Sensor Distance Accuracy Study

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

Diabetes Trials in Other Cities

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Follow-Up Study for Exubera

Testing the Developmental Origins Hypothesis

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

DPBRN Blood Sugar Testing in Dental Patients

A Study for Patients With Type 2 Diabetes Mellitus

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

Dapagliflozin DPPIV Inhibitor add-on Study

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Screening for Early Evidence of Diabetes

Other Conditions in Portland